Fertility and Sterility
Volume 90, Issue 6 , Pages 2172-2178 , December 2008

Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome

Received 13 November 2006 ,Revised 24 October 2007 ,Accepted 24 October 2007.

References 

  1. Brinsden P, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol. 1995;102:767–772
  2. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril. 1992;58:249–261
  3. Shapiro BS, Daneshmand ST, Garner FG, Aguirre M, Ross R, Morris S. Effect of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization. Fertil Stertil. 2005;84:93–98
  4. Abdalla H, Ah-Moye M, Brinsden P, Howe DL, Okonofua F, Craft I. The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program. Fertil Steril. 1987;48:958–963
  5. Schmidt DW, Maier DB, Nulsen JC, Benadiva CA. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization. Fertil Stertil. 2004;82:841–846
  6. Garcia-Velasco JA, Isaza V, Quea G, Pellicer A. Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?. Fertil Stertil. 2006;85:547–554
  7. Kovacs P, Matyas S, Kaali SG. Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders. Fertil Steril. 2006;85:913–917
  8. Waldenstrom U, Kahn J, Marsk L, Nilsson S. High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by “prolonged coasting” of very hyperstimulated patients: a multicentric study. Hum Reprod. 1999;14:294–297
  9. D'Angelo A, Amso N. “Coasting” (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev. 2002;3:CD002811
  10. Al-Shawaf T, Zosmer A, Hussein S, Tozer A, Panay N, Wilson C, et al. Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified “coasting” strategy based on ultrasound for identification of high-risk patients. Hum Reprod. 2001;16:24–30
  11. Ulug U, Bahceci M, Erden HF, Shalev E, Ben-Shlomo I. The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles. Hum Reprod. 2002;17:310–313
  12. Moreno L, Diaz I, Pacheco A, Zuniga A, Requena A, Garcia-Velasco JA. Extended coasting duration exerts a negative impact on IVF cycles outcome due to premature luteinization. Reprod Biomed Online. 2004;9:500–504
  13. Isaza V, Garcia-Velasco JA, Scheffer B, Remohi J, Simon C, Pellicer A. El coasting es eficaz en la prevencion del sindrome de hiperestimulacion ovarica y no afecta los resultados de la fecundacion in vitro. Progr Obstet Ginecol. 2001;44:482–489
  14. Isaza V, Garcia-Velasco JA, Aragones M, Remohi J, Simon C, Pellicer A. Oocyte and embryo quality after coasting: the experience from oocyte donation. Hum Reprod. 2002;17:1777–1782
  15. Mansour R, Aboulghar M, Serour G, Amin Y, Abou-Setta AM. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome. Hum Reprod. 2005;20:3167–3172
  16. Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classification and critical analysis of preventive measures. Hum Reprod Update. 2003;9:275–289
  17. Levinsohn-Tavor O, Friedler S, Schachter M, Raziel A, Strassburger D, Ron-El R. Coasting-what is the best formula?. Hum Reprod. 2003;18:937–940
  18. Whelan JG, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril. 2000;73:883–896
  19. Tortoriello DV, McGovern PG, Colon JM, Skurnick JH, Lipetz K, Santoro N. “Coasting does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients. Fertil Steril. 1998;69:454–460
  20. Ulug U, Ben-Shlomo I, Bahceci M. Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian stimulation for assisted conception. Fertil Steril. 2004;82:338–342
  21. Benadiva CA, Davis O, Kilgman I, Moomjy M, Liu H-C, Rosenwaks Z. Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil Steril. 1997;67:724–727
  22. Dhont M, Van der Straeten F, De Sutter P. Prevention of severe ovarian hyperstimulation by coasting. Fertil Steril. 1998;70:847–850
  23. Lee C, Tummon I, Martin J, Nisker J, Power S, Tekpetey F. Dose withholding gonadotropin administration prevent severe ovarian hyperstimulation syndrome?. Hum Reprod. 1998;13:1157–1158
  24. Fluker MR, Hooper WM, Yuzpe AA. Withholding gonadotropins (“coasting”) to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles. Fertil Steril. 1999;71:294–301
  25. Egbase PE, Al Sharhan M, Grudzinskas JG. Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study. Hum Reprod. 1999;14:1421–1425
  26. Chen CD, Chao KH, Yang JH, Ceh SU, Ho HN, Yang YS. Comparison of coasting and intravenous albumin in the prevention of ovarian hyperstimulation syndrome. Fertil Steril. 2003;80:86–90
  27. Hershlag A, Zinger M, Lesser M, Scholl G, Bjornson L. Is chemiluminescent immunoassay an appropriate substitution for radioimmunoassay in monitoring estradiol levels?. Fertil Steril. 2000;73:1174–1178
  28. Gustofson RL, Segars JH, Larsen FW. Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome. Hum Reprod. 2006;21:2830–2837
  29. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online. 2007;14:640–649
  30. Sher G, Zouves C, Feinman M, Maassarani G. “Prolonged coasting”: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in vitro fertilization. Hum Reprod. 1995;10:3107–3109
  31. Chen D, Burmeister L, Goldschlag D, Rosenwaks Z. Ovarian hyperstimulation syndrome: strategies for prevention. Reprod Biomed Online. 2003;7:43–49
  32. Montgomery Rice V, Limback SD, Roby KF, Terranova PF. Differential responses of granulosa cells from small and large follicles to follicle stimulating hormone (FSH) during the menstrual cycle and acyclicity: effects of tumor necrosis factor-alpha. Hum Reprod. 1998;13:1285–1291
  33. Tozer AJ, Iles RK, Iammarrone E, Gillott CMY, Al-Shawaf T, Grudzinskas JG. The effects of “coasting” on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome. Hum Reprod. 2004;19:522–528
  34. Egbase PE, Al Sharhan M, Berlingieri P, Grudzinskas JG. Serum estradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproductive treatment. Hum Reprod. 2000;15:2082–2086

PII: S0015-0282(07)03916-7

doi: 10.1016/j.fertnstert.2007.10.033

Fertility and Sterility
Volume 90, Issue 6 , Pages 2172-2178 , December 2008

Article Tools

* Image Usage & Resolution